Physician profile
Jonathan A Lowe
NPI 1114199304
$864.72
in general payments reported to CMS, 2019-2025
12 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $269 · 2024: $410 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $181.26 | 2023-2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Alkermes, INC. | $139.12 | 2023-2025 | Vivitrol, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2024 | Abilify Asimtufii, Abilify Maintena |
| Braeburn INC. | $74.15 | 2023-2025 | Brixadi |
| Novo Nordisk INC | $69.90 | 2024-2025 | Wegovy |
| United Therapeutics Corporation | $65.91 | 2024 | Tyvaso |
| Indivior INC. | $65.85 | 2023-2025 | Sublocade |
| Boston Scientific Corporation | $44.43 | 2023-2024 | Latitude Communicator Power Supply, Rhythmia Mapping System |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $30.24 | 2025 | Caplyta |
| Novartis Pharmaceuticals Corporation | $25.08 | 2024 | |
| Collegium Pharmaceutical, INC. | $23.50 | 2025 | Jornay Pm |
| Alnylam Pharmaceuticals INC. | $20.28 | 2024 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.